checkedPsychopharmacology and Psychiatry Updates2026-11-08last verified 2026-11-08

did the european psychiatry catatonia review include 79 articles, 175 trials and 100 patients?

verdict: undersold
the real number is bigger, or worse, than claimed
“The authors ultimately included 79 articles involving 175 antipsychotic trials in 100 patients.”

a guest, Dr. Scott Beach (psychiatrist presenting the review) said on Psychopharmacology and Psychiatry Updates, 2026-11-08, at 05:11. hear it in context → the speaker cited: a recent systematic review in European Psychiatry.

the episode: Catatonia: Should Antipsychotics Always Be Avoided? (at 05:11). we link the show's own page; we do not re-host audio.

first, the part that holds

the review exists and the speaker named it correctly: a 2025 systematic review in European Psychiatry on antipsychotics in catatonia included 79 articles and 175 antipsychotic trials. the speaker had both of those numbers right.

what we found when we went and looked

we read the published article on the journal's site three times, through the abstract, the full-text reader and the article landing page. the review screened 6,219 records and included 79 full-text articles. the abstract states "we identified 175 antipsychotic trials (in 110 patients)", and the main text repeats "175 distinct antipsychotic trials occurring in 110 patients." the speaker said 100 patients. the record says 110. the speaker therefore understated the size of the evidence base by 10 patients. the slip is small, and it does not change what the review found.

assertion by assertion

assertionverdictwhat the record says
the systematic review on antipsychotics in catatonia was published in European Psychiatryconfirmedthe review was published in European Psychiatry in 2025 (volume 68, issue 1, e48; doi 10.1192/j.eurpsy.2025.9) under the title 'the use of antipsychotics in the treatment of catatonia: a systematic review'. [1][2]
the review included 79 articlesconfirmedthe abstract says "after screening 6,219 records, 79 full-text articles were included." the main text says 125 articles were assessed in full and 79 of them were included. [1][2]
the 79 articles covered 175 antipsychotic trialsconfirmedthe abstract says "we identified 175 antipsychotic trials." here a 'trial' means one documented attempt at giving an antipsychotic to one patient. it does not mean a randomized controlled trial. [1][2][3]
the trials were in 100 patientsundersoldthe abstract gives the trials "(in 110 patients)", and the main text says "175 distinct antipsychotic trials occurring in 110 patients were analyzed." the speaker's figure is 10 patients short. both the abstract and the main text use 110. [1][2][3]
the evidence comes mostly from case reports, and antipsychotics were judged beneficial in 60% of the trialsconfirmed148 of the 175 trials were taken from 77 case reports. the authors rated antipsychotic use as beneficial in 60.0% of trials, neutral in 29.1% and harmful in 10.9%. they also caution that these figures show "only the frequency of events reported in the literature, not the frequency of occurrence in real-world practice." [1][2][3]

both directions

for the speaker: the speaker named the right journal and the right review. two of the three numbers, 79 articles and 175 antipsychotic trials, match the abstract exactly. the speaker also kept the paper's own unit, 'antipsychotic trials', which is the authors' term for individual treatment attempts.

against: the patient count is wrong. the paper says 110 patients in both the abstract and the main text, and the speaker said 100. the difference is small, but it is a clause of the claim, so the claim as published cannot be marked confirmed. there is a second issue a listener could miss. the word 'trials' sounds like controlled studies, but most of the 175 trials came from case reports (148 trials from 77 case reports). the authors themselves warn that case reports are subject to publication bias, recall bias and overinterpretation.

what this cannot say

we checked the numbers against the published version of the article on the journal's own site. we could not load the pubmed record in this session, so we did not cross-check the indexed abstract there. some secondary summaries that came up in our search also use 100 patients. we did not read or cite those summaries, so we cannot say where the 100 figure came from. on the review's own limits: it counts what was reported in published cases, not how often antipsychotics help or harm catatonia in practice. the benefit and harm percentages should not be read as response rates.

sources, each one fetched and read

  1. Redon M, et al. The use of antipsychotics in the treatment of catatonia: a systematic review. European Psychiatry. 2025;68(1):e48. doi:10.1192/j.eurpsy.2025.9 What we read there: after screening 6,219 records, 79 full-text articles were analyzed, covering 175 antipsychotic trials in 110 patients; antipsychotic use was considered beneficial in 60.0% of the trials, neutral in 29.1%, and harmful in 10.9%. Fetched 2026-11-08 (HTTP 200). https://www.cambridge.org/core/product/332FE3F1201E16C3F67ECBB059DA85DD
  2. Redon M, et al. European Psychiatry 2025;68(1):e48, full text (Cambridge Core reader) What we read there: abstract: "After screening 6,219 records, 79 full-text articles were included. Among them, we identified 175 antipsychotic trials (in 110 patients)." main text: "148 antipsychotic trials were extracted from 77 case reports. As such, 175 distinct antipsychotic trials occurring in 110 patients were analyzed." Fetched 2026-11-08 (HTTP 200). https://www.cambridge.org/core/product/332FE3F1201E16C3F67ECBB059DA85DD/core-reader
  3. Redon M, et al. European Psychiatry 2025;68(1):e48, article page (doi:10.1192/j.eurpsy.2025.9 resolves here) What we read there: "Among them, we identified 175 antipsychotic trials (in 110 patients)." case reports are "primarily written to report unusual events and are subject to various biases, such as publication bias, recall bias, and overinterpretation"; results reflect "only the frequency of events reported in the literature, not the frequency of occurrence in real-world practice." Fetched 2026-11-08 (HTTP 200). https://www.cambridge.org/core/product/identifier/S0924933825000094/type/journal_article

speakers are described by role, not named. one sentence is quoted under fair use, with attribution and a link to the original at the timestamp; we do not re-host audio or video. nothing on this page is a reason to start, stop or change a medication. if you have the file behind anything marked unverifiable, the research board is where people can answer. adam